Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Foteini Strimenopoulou
Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”
Arthritis Research & Therapy
Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Safety of Adalimumab in Japanese Patients With Psoriatic Arthritis and Inadequate Response to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): A Prospective, Observational Study
Modern Rheumatology
Medicine
Rheumatology
AB0490 Evaluation of Inhibitory Factor of Radiographic Progression by Iguratimod Add-On Therapy in Rheumatoid Arthritis Patients With Inadequate Responses to Disease-Modifying Anti-Rheumatic Drugs
PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study
Modern Rheumatology
Medicine
Rheumatology
